CMS proposes ASP+4% for hospital outpatient drugs
Executive Summary
CMS is proposing to lower the rate at which hospital outpatient drugs are reimbursed from the current average sales price plus 5 percent to ASP plus 4 percent for 2009. According to the outpatient prospective payment system proposed rule for 2009, released July 3, CMS is proposing "to continue our policy of making a combined payment for the acquisition and pharmacy overhead costs of separately payable drugs and biologicals at an equivalent average ASP-based amount calculated based on our standard methodology of estimating drug costs from claims." The agency added that ASP plus 4 percent "is the best currently available proxy for average hospital acquisition cost and associated pharmacy overhead cost.
You may also be interested in...
Increase In Pay For Part B Hospital Outpatient Drugs Needed, Groups Tell CMS
CMS' proposal to drop Medicare Part B drug reimbursement to average sales price plus 4 percent in the hospital outpatient setting is being met with calls for the agency to return to ASP plus 6 percent, the same rate physicians are reimbursed for drugs administered in their offices
Eleven Drugs Lose Medicare Part B Pass-Through Status In 2009 Proposal
CMS will issue its annual proposed changes to the list of drugs and biologicals designated as "pass-through" products under Medicare Part B, with 11 losing that status for 2009, 10 remaining on the list, and no drugs added
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.